Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer's disease

REFERENCES

• Shrestha R, Wuerz T, Appleby BS. Rapidly progressive young-onset dementias: neuropsychiatric aspects. Psychiatr Clin North Am 2015; 38:221-32; PMID:25998112; http://dx.doi.org/10.1016/j.psc.2015.01.001
   PubMed Web of Science ®Google Scholar
• Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6:734-46; PMID:17616482; http://dx.doi.org/10.1016/S1474-4422(07)70178-3
   PubMed Web of Science ®Google Scholar
• Schmidt C, Wolff M, Weitz M, Bartlau T, Korth C, Zerr I. Rapidly progressive Alzheimer disease. Arch Neurol 2011; 68:1124-30; PMID:21911694; http://dx.doi.org/10.1001/archneurol.2011.189
   PubMed Web of Science ®Google Scholar
• Cohen ML, Kim C, Haldiman T, ElHag M, Mehndiratta P, Pichet T, Lissemore F, Shea M, Cohen Y, Chen W, et al. Rapidly progressive Alzheimer's disease features distinct structures of amyloid-beta. Brain 2015; 138(Pt 4):1009-22.
   PubMed Web of Science ®Google Scholar
• Tosto G, Gasparini M, Brickman AM, Letteri F, Renie R, Piscopo P, Talarico G, Canevelli M, Confaloni A, Bruno G. Neuropsychological predictors of rapidly progressive Alzheimer's disease. Acta Neurol Scand 2015; 132(6):417-22; PMID:25903925
   PubMed Web of Science ®Google Scholar
• Schmidt C, Wolff M, von Ahsen N, Zerr I. Alzheimer's disease: genetic polymorphisms and rate of decline. Dement Geriatr Cogn Disord 2012; 33:84-9; PMID:22414550; http://dx.doi.org/10.1159/000336790
   PubMed Web of Science ®Google Scholar
• Schmidt C, Redyk K, Meissner B, Krack L, von Ahsen N, Roeber S, Kretzschmar H, Zerr I. Clinical features of rapidly progressive Alzheimer disease. Dement Geriatr Cogn Disord 2010; 29:371-8; PMID:20453509; http://dx.doi.org/10.1159/000278692
   PubMed Web of Science ®Google Scholar
• Pocchiari M, Puopolo M, Croes EA, Budka H, Gelpi E, Collins S, Lewis V, Sutcliffe T, Guilivi A, Delasnerie-Laupretre N, et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 2004; 127:2348-59; PMID:15361416; http://dx.doi.org/10.1093/brain/awh249
   PubMed Web of Science ®Google Scholar
• Mann UM, Mohr E, Chase TN. Rapidly progressive Alzheimer's disease. Lancet 1989; 2:799; PMID:2571032; http://dx.doi.org/10.1016/S0140-6736(89)90857-X
   PubMed Web of Science ®Google Scholar
• Schmidt C, Haik S, Satoh K, Rabano A, Martinez-Martin P, Roeber S, Brandel JP, Calero-Lara M, de Pedro-Cuesta J, Laplanche JL, et al. Rapidly progressive Alzheimer's disease: a multicenter update. J Alzheimers Dis 2012; 30:751-6; PMID:22460329
   PubMed Web of Science ®Google Scholar
• Goedert M. Oskar Fischer and the study of dementia. Brain 2009; 132:1102-11; PMID:18952676; http://dx.doi.org/10.1093/brain/awn256
   PubMed Web of Science ®Google Scholar
• Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991; 82:239-59; http://dx.doi.org/10.1007/BF00308809
   PubMed Web of Science ®Google Scholar
• Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol 2012; 71:362-81; PMID:22487856; http://dx.doi.org/10.1097/NEN.0b013e31825018f7
   PubMed Web of Science ®Google Scholar
• Hyman BT, Trojanowski JQ. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 1997; 56:1095-7; PMID:9329452; http://dx.doi.org/10.1097/00005072-199710000-00002
   PubMed Web of Science ®Google Scholar
• Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, Yen SH, Aronson MK. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 1992; 13:179-89; PMID:1311804; http://dx.doi.org/10.1016/0197-4580(92)90027-U
   PubMed Web of Science ®Google Scholar
• Thal DR, Rub U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002; 58:1791-800; PMID:12084879; http://dx.doi.org/10.1212/WNL.58.12.1791
   PubMed Web of Science ®Google Scholar
• Thal DR, Beach TG, Zanette M, Heurling K, Chakrabarty A, Ismail A, Smith AP, Buckley C. [(18)F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid-beta pathology. Alzheimers Dement 2015; 11:975-85; PMID:26141264; http://dx.doi.org/10.1016/j.jalz.2015.05.018
   PubMed Web of Science ®Google Scholar
• Montine TJ, Monsell SE, Beach TG, Bigio EH, Bu Y, Cairns NJ, Frosch M, Henriksen J, Julia Kofler, Kukull WA, et al. Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease. Alzheimers Dement 2015; pii: S1552–5260(15)02669–2; http://dx.doi.org/10.1016/j.jalz.2015.07.492.
   Web of Science ®Google Scholar
• Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7:280-92; PMID:21514248; http://dx.doi.org/10.1016/j.jalz.2011.03.003
   PubMed Web of Science ®Google Scholar
• Yu L, Boyle PA, Leurgans S, Schneider JA, Kryscio RJ, Wilson RS, Bennett DA. Effect of common neuropathologies on progression of late life cognitive impairment. Neurobiol Aging 2015; 36:2225-31; PMID:25976345; http://dx.doi.org/10.1016/j.neurobiolaging.2015.04.006
   PubMed Web of Science ®Google Scholar
• Josephs KA, Nelson PT. Unlocking the mysteries of TDP-43. Neurology 2015; 84:870-1; PMID:25653288; http://dx.doi.org/10.1212/WNL.0000000000001322
   PubMed Web of Science ®Google Scholar
• Akiyama H, Mori H, Saido T, Kondo H, Ikeda K, McGeer PL. Occurrence of the diffuse amyloid beta-protein (Abeta) deposits with numerous Abeta-containing glial cells in the cerebral cortex of patients with Alzheimer's disease. Glia 1999; 25:324-31; PMID:10028915; http://dx.doi.org/10.1002/(SICI)1098-1136(19990215)25:4%3c324::AID-GLIA2%3e3.0.CO;2-5
   PubMed Web of Science ®Google Scholar
• Drummond ES, Nayak S, Ueberheide B, Wisniewski T. Proteomic analysis of neurons microdissected from formalin-fixed, paraffin-embedded Alzheimer's disease brain tissue. Sci Rep 2015; 5:15456; PMID:26487484; http://dx.doi.org/10.1038/srep15456
   PubMed Web of Science ®Google Scholar
• Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, et al. Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease: A Genome-Wide Association Study. JAMA Neurol 2014; 71(11):1394-404; PMID:25199842
   PubMed Web of Science ®Google Scholar
• Ridge PG, Mukherjee S, Crane PK, Kauwe JS, Alzheimer's Disease Genetics C. Alzheimer's disease: analyzing the missing heritability. PLoS One 2013; 8:e79771; PMID:24244562; http://dx.doi.org/10.1371/journal.pone.0079771
   PubMed Web of Science ®Google Scholar
• Hardy J. Has the amyloid cascade hypothesis for Alzheimer's disease been proved? Curr Alzheimer Res 2006; 3:71-3; PMID:16472206; http://dx.doi.org/10.2174/156720506775697098
   PubMedGoogle Scholar
• Schellenberg GD, Montine TJ. The genetics and neuropathology of Alzheimer disease. Acta Neuropathol 2012; 124:305-23; PMID:22618995; http://dx.doi.org/10.1007/s00401-012-0996-2
   PubMed Web of Science ®Google Scholar
• Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, DeStafano AL, Bis JC, Beecham GW, Grenier-Boley B, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 2013; 45:1452-8; PMID:24162737; http://dx.doi.org/10.1038/ng.2802
   PubMed Web of Science ®Google Scholar
• Safar JG, Xiao X, Kabir ME, Chen S, Kim C, Haldiman T, Cohen Y, Chen W, Cohen ML, Surewicz WK. Structural determinants of phenotypic diversity and replication rate of human prions. PLoS Pathog 2015; 11:e1004832; PMID:25875953; http://dx.doi.org/10.1371/journal.ppat.1004832
   PubMed Web of Science ®Google Scholar
• Safar JG. Molecular Mechanisms Encoding Quantitative and Qualitative Traits of Prion Strains. In: Gambetti P, ed. Prions and Diseases. New York: Springer Verlag, 2012.
   Google Scholar
• Safar JG. Molecular pathogenesis of sporadic prion diseases in man. Prion 2012; 6:108-15; PMID:22421210; http://dx.doi.org/10.4161/pri.18666
   PubMed Web of Science ®Google Scholar
• Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, Cohen FE, Prusiner SB. Eight prion strains have PrPSc molecules with different conformations. Nat Med 1998; 4:1157-65; PMID:9771749; http://dx.doi.org/10.1038/2654
   PubMed Web of Science ®Google Scholar
• Shirley BA, ed. Protein Stability and Folding: Theory and Practice. Totowa, New Jersey: Humana Press, 1995.
   Google Scholar
• Colby DW, Wain R, Baskakov IV, Legname G, Palmer CG, Nguyen HO, Lemus A, Cohen FE, DeArmond SJ, Prusiner SB. Protease-sensitive synthetic prions. PLoS Pathog 2010; 6:e1000736; PMID:20107515; http://dx.doi.org/10.1371/journal.ppat.1000736
   PubMed Web of Science ®Google Scholar
• Peretz D, Williamson RA, Legname G, Matsunaga Y, Vergara J, Burton D, DeArmond SJ, Prusiner SB, Scott MR. A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron 2002; 34:921-32; PMID:12086640; http://dx.doi.org/10.1016/S0896-6273(02)00726-2
   PubMed Web of Science ®Google Scholar
• Choi YP, Peden AH, Groner A, Ironside JW, Head MW. Distinct stability states of disease-associated human prion protein identified by conformation-dependent immunoassay. J Virol 2011; 84:12030-8; http://dx.doi.org/10.1128/JVI.01057-10
   Web of Science ®Google Scholar
• Pirisinu L, Di Bari M, Marcon S, Vaccari G, D'Agostino C, Fazzi P, Esposito E, Galeno R, Langeveld J, Agrimi U, et al. A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrP. PLoS ONE 2011; 5:e12723; http://dx.doi.org/10.1371/journal.pone.0012723
   Web of Science ®Google Scholar
• Kim C, Haldiman T, Surewicz K, Cohen Y, Chen W, Blevins J, Sy MS, Cohen M, Kong Q, Telling GC, et al. Small Protease Sensitive Oligomers of PrP(Sc) in Distinct Human Prions Determine Conversion Rate of PrP(C). PLoS Pathog 2012; 8:e1002835; PMID:22876179; http://dx.doi.org/10.1371/journal.ppat.1002835
   PubMed Web of Science ®Google Scholar
• Kim C, Haldiman T, Cohen Y, Chen W, Blevins J, Sy MS, Cohen M, Safar JG. Protease-Sensitive Conformers in Broad Spectrum of Distinct PrP Structures in Sporadic Creutzfeldt-Jakob Disease Are Indicator of Progression Rate. PLoS Pathog 2011; 7:e1002242; PMID:21931554; http://dx.doi.org/10.1371/journal.ppat.1002242
   PubMed Web of Science ®Google Scholar
• Lesne SE, Sherman MA, Grant M, Kuskowski M, Schneider JA, Bennett DA, Ashe KH. Brain amyloid-beta oligomers in ageing and Alzheimer's disease. Brain 2013; 136:1383-98; PMID:23576130; http://dx.doi.org/10.1093/brain/awt062
   PubMed Web of Science ®Google Scholar
• Masters CL, Selkoe DJ. Biochemistry of amyloid beta-protein and amyloid deposits in Alzheimer disease. Cold Spring Harb Perspect Med 2012; 2:a006262; PMID:22675658; http://dx.doi.org/10.1101/cshperspect.a006262
   PubMed Web of Science ®Google Scholar
• Benilova I, Karran E, De Strooper B. The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci 2012; 15:349-57; PMID:22286176; http://dx.doi.org/10.1038/nn.3028
   PubMed Web of Science ®Google Scholar
• Hayden EY, Teplow DB. Amyloid β-protein oligomers and Alzheimer's disease. Alzheimers Res Ther 2013; 5:60; PMID:24289820; http://dx.doi.org/10.1186/alzrt226
   PubMed Web of Science ®Google Scholar
• Paravastu AK, Leapman RD, Yau WM, Tycko R. Molecular structural basis for polymorphism in Alzheimer's beta-amyloid fibrils. Proc Natl Acad Sci U S A 2008; 105:18349-54; PMID:19015532; http://dx.doi.org/10.1073/pnas.0806270105
   PubMed Web of Science ®Google Scholar
• Tycko R. Molecular structure of amyloid fibrils: insights from solid-state NMR. Q Rev Biophys 2006; 39:1-55; PMID:16772049; http://dx.doi.org/10.1017/S0033583506004173
   PubMed Web of Science ®Google Scholar
• Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 2012; 11:618-28; PMID:22710755; http://dx.doi.org/10.1016/S1474-4422(12)70063-7
   PubMed Web of Science ®Google Scholar
• Guo JL, Lee VM. Neurofibrillary tangle-like tau pathology induced by synthetic tau fibrils in primary neurons over-expressing mutant tau. FEBS Lett 2013; 587:717-23; PMID:23395797; http://dx.doi.org/10.1016/j.febslet.2013.01.051
   PubMed Web of Science ®Google Scholar
• Guo JL, Covell DJ, Daniels JP, Iba M, Stieber A, Zhang B, Riddle DM, Kwong LK, Xu Y, Trojanowski JQ, et al. Distinct α-synuclein strains differentially promote tau inclusions in neurons. Cell 2013; 154:103-17; PMID:23827677; http://dx.doi.org/10.1016/j.cell.2013.05.057
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Biology and genetics of prions causing neurodegeneration. Annu Rev Genet 2013; 47:601-23; PMID:24274755; http://dx.doi.org/10.1146/annurev-genet-110711-155524
   PubMed Web of Science ®Google Scholar
• Jucker M, Walker LC. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 2013; 501:45-51; PMID:24005412; http://dx.doi.org/10.1038/nature12481
   PubMed Web of Science ®Google Scholar
• Prusiner SB, Woerman AL, Mordes DA, Watts JC, Rampersaud R, Berry DB, Patel S, Oehler A, Lowe JK, Kravitz SN, et al. Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci U S A 2015; 112:E5308-17; PMID:26324905; http://dx.doi.org/10.1073/pnas.1514475112
   PubMed Web of Science ®Google Scholar
• Jaunmuktane Z, Mead S, Ellis M, Wadsworth JD, Nicoll AJ, Kenny J, Launchbury F, Linehan J, Richard-Loendt A, Walker AS, et al. Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy. Nature 2015; 525:247-50; PMID:26354483; http://dx.doi.org/10.1038/nature15369
   PubMed Web of Science ®Google Scholar
• Lu JX, Qiang W, Yau WM, Schwieters CD, Meredith SC, Tycko R. Molecular structure of beta-amyloid fibrils in Alzheimer's disease brain tissue. Cell 2013; 154:1257-68; PMID:24034249; http://dx.doi.org/10.1016/j.cell.2013.08.035
   PubMed Web of Science ®Google Scholar
• Cummings JL. Biomarkers in Alzheimer's disease drug development. Alzheimers Dement 2011; 7:e13-44; PMID:21550318; http://dx.doi.org/10.1016/j.jalz.2010.06.004
   PubMedGoogle Scholar
• Colom LV, Perry G, Kuljis RO. Tackling the elusive challenges relevant to conquering the 100-plus year old problem of Alzheimer disease. Curr Alzheimer Res 2013; 10:108-16; PMID:23368433
   PubMed Web of Science ®Google Scholar
• Kabir ME, Safar JG. Implications of prion adaptation and evolution paradigm for human neurodegenerative diseases. Prion 2014; 8:111-6; PMID:24401672; http://dx.doi.org/10.4161/pri.27661
   PubMed Web of Science ®Google Scholar
• Haldiman T, Kim C, Cohen Y, Chen W, Blevins J, Qing L, Cohen ML, Langeveld J, Telling GC, Kong Q, et al. Coexistence of Distinct Prion Types Enables Conformational Evolution of Human PrPSc by Competitive Selection. J Biol Chem 2013; 288(41):29846-61; PMID:23974118
   PubMed Web of Science ®Google Scholar